A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection.

Source:http://linkedlifedata.com/resource/pubmed/id/10068580

Download in:

View as

General Info

PMID
10068580